Cargando…
Retracted: MiR-373 Inhibits the Epithelial-Mesenchymal Transition of Prostatic Cancer via Targeting Runt-Related Transcription Factor 2
Autor principal: | Healthcare Engineering, Journal of |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10447104/ https://www.ncbi.nlm.nih.gov/pubmed/37621633 http://dx.doi.org/10.1155/2023/9836954 |
Ejemplares similares
-
MiR-373 Inhibits the Epithelial-Mesenchymal Transition of Prostatic Cancer via Targeting Runt-Related Transcription Factor 2
por: Pang, Jianyi, et al.
Publicado: (2021) -
Retracted: MiR-483 Promotes Colorectal Cancer Cell Biological Progression by Directly Targeting NDRG2 through Regulation of the PI3K/AKT Signaling Pathway and Epithelial-to-Mesenchymal Transition
por: Engineering, Journal of Healthcare
Publicado: (2022) -
Retracted: The Effect of Suppression Taurine on Relocation and Epithelial-Mesenchymal Transition in Mankind Lung Cancer Cells
por: Healthcare Engineering, Journal of
Publicado: (2023) -
Retracted: Analysis on Value of Applying Serum miR-144 and miR-221 Levels in Diagnosing Atherosclerosis
por: Engineering, Journal of Healthcare
Publicado: (2023) -
Retracted: Clinical Potential of miR-451 and miR-506 as a Prognostic Biomarker in Patients with Breast Cancer
por: Healthcare Engineering, Journal of
Publicado: (2023)